Blame | Last modification | View Log | Download | RSS feed
\name{aml}\alias{aml}\title{Remission Times for Acute Myelogenous Leukaemia}\description{The \code{aml} data frame has 23 rows and 3 columns.A clinical trial to evaluate the efficacy of maintenance chemotherapy foracute myelogenous leukaemia wasconducted by Embury et al. (1977) at Stanford University. After reaching astage of remission through treatment by chemotherapy, patients were randomizedinto two groups. The first group received maintenance chemotherapy and thesecond group did not. The aim of the study was to see if maintenancechemotherapy increased the length of the remission. The data here formed apreliminary analysis which was conducted in October 1974.}\usage{aml}\format{This data frame contains the following columns:\describe{\item{\code{time}}{The length of the complete remission (in weeks).}\item{\code{cens}}{An indicator of right censoring. 1 indicates that the patient had a relapseand so \code{time} is the length of the remission. 0 indicates that the patienthad left the study or was still in remission in October 1974, that is thelength of remission is right-censored.}\item{\code{group}}{The group into which the patient was randomized. Group 1 receivedmaintenance chemotherapy, group 2 did not.}}}\source{The data were obtained fromMiller, R.G. (1981) \emph{Survival Analysis}. John Wiley.}\references{Davison, A.C. and Hinkley, D.V. (1997)\emph{Bootstrap Methods and Their Application}. Cambridge University Press.Embury, S.H, Elias, L., Heller, P.H., Hood, C.E., Greenberg, P.L. andSchrier, S.L. (1977) Remission maintenance therapy in acute myelogenousleukaemia. \emph{Western Journal of Medicine}, \bold{126}, 267-272.}\note{Package \pkg{survival} also has a dataset \code{aml}. It is the samedata with different names and with \code{group} replaced by a factor\code{x}.}\keyword{datasets}% Converted by Sd2Rd version 1.15.